Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Integrin alpha2beta1, also known as VLA-2, is a heterodimeric transmembrane receptor composed of the α2 (CD49b) and β1 (CD29) subunits. It functions primarily as a collagen receptor, mediating cell adhesion to various types of collagen in the extracellular matrix. It plays a role in cell migration, costimulation of T cells, and resistance to apoptosis. It is implicated in autoimmune diseases, inflammation, and tumor metastasis.
Not applicable, target of drug resistance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Integrin alpha2beta1 (VLA-2).